Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Effects of diet and exercise on patients with peripheral artery disease

Official title: The Effects of Diet and Exercise Interventions in Peripheral Artery Disease

Run by University of Oklahoma · NCT03845036 · Data updated 2026-11-12

This study is testing whether a special diet and exercise program together can help people with peripheral artery disease walk better and feel healthier compared to just exercising at home.

More Peripheral Artery Disease trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment150 (estimated)
SponsorUniversity of Oklahoma
Academic / other
Locations1 site (Oklahoma City, Oklahoma)
StatusRecruiting
StartedSeptember 16, 2024
Main results expectedMay 31, 2029
Study endsMay 31, 2029
Registry record updatedApril 17, 2026
Trial IDNCT03845036 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with a history of claudication and a confirmed diagnosis of peripheral artery disease.

Probably not a fit

Patients without peripheral artery disease or those with severe complications such as rest pain or tissue loss due to PAD may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of a combined DASH dietary program and a home-based exercise regimen on patients with peripheral artery disease (PAD). Over three months, participants will be randomly assigned to either the combined intervention or a home-based exercise program alone. The study aims to measure improvements in walking distance, physical function quality of life, microvascular function, and inflammation markers. The hypothesis is that the combined approach will yield greater benefits than exercise alone.

Why it matters

Potential benefit: If successful, this study could significantly improve the quality of life and physical capabilities of patients with peripheral artery disease.

How similar studies have gone: Other studies have shown promising results with dietary and exercise interventions for similar conditions, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. History of claudication,
2. Presence of PAD, defined by meeting at least one of the following criteria (ABI at rest \< 0.90, or \> 20% decrease in ABI following a heel-rise exercise test in patients with a normal ABI at rest (\> 0.90), or history of peripheral revascularization.

Exclusion Criteria:

1. absence of PAD, defined by meeting all of the following 3 criteria (ABI at rest \> 0.90), \< 20% decrease in ABI following a heel-rise exercise test, and no history of peripheral revascularization,
2. non-compressible vessels (ABI \> 1.40),
3. rest pain due to PAD (Fontaine stage III; Rutherford Grade II),
4. tissue loss due to PAD (Fontaine stage IV; Rutherford Grade III),
5. use of medications indicated for the treatment of intermittent claudication (cilostazol and pentoxifylline) initiated within three months prior to investigation,
6. peripheral revascularization within one month prior to investigation,
7. active cancer,
8. end stage renal disease defined as stage 5 chronic kidney disease,
9. medical conditions that are contraindicative for exercise according to the American College of Sports Medicine,
10. cognitive dysfunction (mini-mental state examination score \< 24), and
11. failure to complete the baseline tests within three weeks.

Where it's running

  • O'Donoghue Research Building, University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma, United States
    Recruiting

Study contacts

  • Principal investigator: Andrew Gardner, Ph.D. — Professor, Department of Medicine, Cardiology
  • Study coordinator: Andrew Gardner, Ph.D.
  • Email: andrew-gardner@ouhsc.edu
  • Phone: 405-271-4742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.